ストックスクリーナーアプリを入手
69.88
0.39%
0.265
前日終値:
$69.61
開ける：
$69.3
24時間の取引高:
74,912
Relative Volume:
0.06
時価総額：
$3.71B
収益：
-
当期純損益:
$-38.99M
株価収益率:
-23.32
EPS:
-2.9966
ネットキャッシュフロー:
$-24.94M
1週間 パフォーマンス:
+1.36%
1か月 パフォーマンス:
-19.19%
6か月 パフォーマンス:
+55.32%
1年 パフォーマンス:
+42.50%
1日の値動き範囲:
$69.17
$70.73
1週間の範囲:
$66.28
$70.73
52週間の値動き範囲:
$41.50
$90.32
Soleno Therapeutics Inc Stock (SLNO) Company Profile
名前
Soleno Therapeutics Inc
セクター
電話
650-213-8444
住所
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
SLNO を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SLNO
Soleno Therapeutics Inc
|
69.87 | 3.53B | 0 | -38.99M | -24.94M | -2.9966 |
|
VRTX
Vertex Pharmaceuticals Inc
|
390.10 | 99.72B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
588.85 | 60.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.56 | 58.15B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
705.14 | 41.45B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
299.22 | 36.69B | 3.81B | -644.79M | -669.77M | -6.24 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-23 | 開始されました | TD Cowen | Buy |
| 2025-03-05 | 再開されました | Stifel | Buy |
| 2024-12-02 | 繰り返されました | Robert W. Baird | Outperform |
| 2024-12-02 | 繰り返されました | Stifel | Buy |
| 2024-09-03 | 開始されました | H.C. Wainwright | Buy |
| 2024-05-10 | 開始されました | Robert W. Baird | Outperform |
| 2024-02-05 | 開始されました | Piper Sandler | Overweight |
| 2024-01-23 | 開始されました | Stifel | Buy |
| 2023-11-21 | 再開されました | Guggenheim | Buy |
| 2020-09-29 | 開始されました | Guggenheim | Buy |
| 2020-01-10 | 開始されました | Craig Hallum | Buy |
| 2019-12-23 | 開始されました | Oppenheimer | Outperform |
| 2018-02-13 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Soleno Therapeutics Inc (SLNO) 最新ニュース
Soleno Therapeutics to Participate in Upcoming September Conferences - GlobeNewswire
Rare Disease Biotech Soleno Therapeutics Lines Up 5 Major Wall Street Healthcare Conference Presentations - Stock Titan
Soleno Therapeutics Inc.’s volatility index tracking explainedJuly 2025 Big Picture & Step-by-Step Swing Trade Plans - Newser
Soleno Therapeutics Inc. stock trend forecast2025 Trading Volume Trends & Real-Time Buy Signal Notifications - Newser
Regression analysis insights on Soleno Therapeutics Inc. performance2025 Risk Factors & Reliable Momentum Entry Alerts - Newser
Soleno Therapeutics (SLNO) Drops Amid Critical Scorpion Report -- Hagens Berman - GlobeNewswire
SOLENO ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
When is the best time to exit Soleno Therapeutics Inc.Portfolio Gains Report & Community Driven Trade Alerts - Newser
Can Soleno Therapeutics Inc. Escape Recent Bear Channel getLinesFromResByArray error: size == 0 - 더경남뉴스
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Soleno Therapeutics, Inc. (SLNO) And Encourages Investors to Reach Out - ACCESS Newswire
Will breakout in Soleno Therapeutics Inc. lead to full recovery2025 Key Highlights & Weekly Setup with ROI Potential - Newser
Is Soleno Therapeutics Inc. forming a bottoming baseQuarterly Portfolio Summary & Daily Chart Pattern Signals - Newser
Why Soleno Therapeutics Inc. stock is on top investor watchlistsMarket Rally & Daily Stock Trend Watchlist - Newser
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc.SLNO - PR Newswire
Securities Litigation and Market Volatility: Assessing the Risks in Soleno Therapeutics (SLNO) - AInvest
Rosen Law Firm Encourages Soleno Therapeutics, Inc. Investors to Inquire About Securities Class Action Investigation – SLNO - Business Wire
Soleno Therapeutics Inc. stock volume spike explained2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Published on: 2025-08-25 10:52:32 - newsyoung.net
Does Soleno Therapeutics Inc. have declining or rising EPSEarnings Risk Summary & Reliable Price Breakout Alerts - theviewers.co.kr
Long term hold vs stop loss in Soleno Therapeutics Inc.Weekly Trade Summary & Real-Time Buy Signal Notifications - Newser
Is Soleno Therapeutics Inc. currently under institutional pressureJuly 2025 Movers & Fast Gain Stock Trading Tips - theviewers.co.kr
Published on: 2025-08-23 19:04:39 - Newser
Will Soleno Therapeutics Inc. Sustain Its Chart BreakoutJuly 2025 Snapshot & Precise Swing Trade Alerts - newsyoung.net
Analyzing drawdowns of Soleno Therapeutics Inc. with statistical toolsJuly 2025 Decliners & Verified Swing Trading Watchlists - Newser
Soleno Therapeutics Inc. stock chart pattern explainedWall Street Watch & Real-Time Chart Breakout Alerts - Newser
Can Soleno Therapeutics Inc. Escape Recent Bear ChannelJuly 2025 PreEarnings & Free Daily Entry Point Trade Alerts - beatles.ru
Can Soleno Therapeutics Inc. sustain its profitabilityJuly 2025 Trends & Verified Chart Pattern Signals - theviewers.co.kr
FDA Approval for its Drug Lifted Soleno Therapeutics (SLNO) Shares by 60% - MSN
Piper Sandler reiterates Overweight rating on Soleno Therapeutics stock - Investing.com
Published on: 2025-08-21 02:28:29 - Newser
Wells Fargo initiates Soleno Therapeutics stock with Overweight rating By Investing.com - Investing.com Nigeria
What machine learning models say about Soleno Therapeutics Inc.2025 Institutional Moves & Daily Stock Momentum Reports - Newser
Wells Fargo initiates Soleno Therapeutics stock with Overweight rating - Investing.com India
Soleno Therapeutics Inc. Hits Price Floor — Bounce IncomingWeekly Stock Analysis & Consistent Profit Trade Alerts - classian.co.kr
Soleno Therapeutics shares rise 1.11% premarket after Wells Fargo initiates coverage with an Overweight rating. - AInvest
Top Analysts Pick: 3 Stocks to Buy Now with Significant Upside - AInvest
Wells Fargo Initiates Soleno Therapeutics at Overweight With $123 Price Target - MarketScreener
INVESTOR ALERT: Investigation of Soleno Therapeutics, Inc. (SLNO) Announced by Holzer & Holzer, LLC - GlobeNewswire
INVESTOR ALERT: Investigation of Soleno Therapeutics, Inc. (SLNO) Announced by Holzer & Holzer, LLC - GlobeNewswire Inc.
Scorpion Capital says remain short Soleno Therapeutics - MarketScreener
Down 21.7% in 4 Weeks, Here's Why Soleno Therapeutics (SLNO) Looks Ripe for a Turnaround - Yahoo Finance
Cantor Fitzgerald reiterates Overweight rating on Soleno Therapeutics stock By Investing.com - Investing.com Australia
Cantor Fitzgerald reiterates Overweight rating on Soleno Therapeutics stock - Investing.com
Soleno Therapeutics shares rise 1.62% premarket after VYKATTM XR approval for PWS treatment. - AInvest
Baird reiterates Outperform rating on Soleno Therapeutics stock amid short report - Investing.com
Soleno Therapeutics plunges after short report from Scorpion Capital - MSN
Soleno Therapeutics stock maintains Buy rating at TD Cowen on strong sales momentum - Investing.com
H.C. Wainwright raises Soleno Therapeutics stock price target to $110 on VYKAT XR outlook - Investing.com
Soleno Therapeutics price target raised to $110 from $100 at H.C. Wainwright - TipRanks
Strong Buy Recommendation for Soleno Therapeutics: Promising Outlook and Impressive Sales Performance of VYKAT XR - TipRanks
Soleno Therapeutics Engages Investors in Roadshow - TipRanks
Soleno Therapeutics Inc (SLNO) 財務データ
収益
当期純利益
現金流量
EPS
Soleno Therapeutics Inc (SLNO) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hirano Patricia C | SEE REMARKS |
Jul 01 '25 |
Sale |
82.76 |
3,830 |
316,971 |
13,206 |
1.41%
7.60%
大文字化:
|
ボリューム (24 時間):